Form 8-K - Current report:
SEC Accession No. 0001493152-21-013862
Filing Date
2021-06-09
Accepted
2021-06-09 07:00:21
Documents
7
Period of Report
2021-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28925
2 ex99-1.htm EX-99.1 46230
3 ex99-1_001.jpg GRAPHIC 4580
4 ex99-1_002.jpg GRAPHIC 51969
5 ex99-1_003.jpg GRAPHIC 133064
6 ex99-1_004.jpg GRAPHIC 36558
7 ex99-1_005.jpg GRAPHIC 457505
  Complete submission text file 0001493152-21-013862.txt   1018163
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 211003952
SIC: 2834 Pharmaceutical Preparations